2018 Heineken Prize for Medicine for Prof Peter Carmeliet for his pioneering research on blood vessel formation

24 April 2018

Professor Peter Carmeliet of the Angiogenesis and Vascular Metabolism Laboratory, VIB-KU Leuven Center for Cancer Biology (CCB), has been awarded the prestigious 2018 Heineken Prize for Medicine (200,000$), for his important and fundamental research into blood vessel formation (angiogenesis) and his most recent innovative achievement in endothelial cell metabolism in angiogenesis. Peter Carmeliet is the first Belgian researcher to receive the Heineken prize for medicine. The prize is considered one of the most important in the scientific community and widely regarded as second only to the Breakthrough and Nobel Prize.

Prof. José van Dijck (President of the Royal Netherlands Academy of Arts and Sciences): “The jury has selected prof. Carmeliet as the winner of the Dr A.H.Heineken Prize for Medicine 2018 for his work on the highly relevant clinical applications in vascular disease and ALS but most significantly his recent discoveries in endothelial cell metabolism.”

Recognition for achievements and vision & strategy for the future
The bi-annual world-wide (for the entire Life Sciences) Heineken Prize for Medicine recognizes and awards unique achievements in the fields of medicine to internationally renowned medical researchers, who have conducted pioneering medical research with high translational potential and whose ongoing research holds realistic promise for future innovative discoveries. The Heineken Prize for Medicine is amongst the most important and highly recognized international research prizes, and winners are selected by a jury of leading international researchers.

International recognition 
Earlier this month Peter Carmeliet received the 46th annual ARC Foundation Leopold Griffuel Award. Receiving these two prestigious prizes on such a short time frame, highlights the impact of Prof Carmeliet’s research in the medical field.

Prof. Peter Carmeliet (VIB-KU Leuven Center for Cancer Biology): “These awards are a great recognition of the work my group has been doing. It is an important impetus to continue to perform top-level research that can impact the lives of patients in the future.”


_DSC7038.jpeg
Peter Carmeliet
©Jussi Puikkonen/KNAW